227 related articles for article (PubMed ID: 17702961)
1. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients.
Schellinger PD; Thomalla G; Fiehler J; Köhrmann M; Molina CA; Neumann-Haefelin T; Ribo M; Singer OC; Zaro-Weber O; Sobesky J
Stroke; 2007 Oct; 38(10):2640-5. PubMed ID: 17702961
[TBL] [Abstract][Full Text] [Related]
2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
3. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.
Thomalla G; Schwark C; Sobesky J; Bluhmki E; Fiebach JB; Fiehler J; Zaro Weber O; Kucinski T; Juettler E; Ringleb PA; Zeumer H; Weiller C; Hacke W; Schellinger PD; Röther J;
Stroke; 2006 Mar; 37(3):852-8. PubMed ID: 16439696
[TBL] [Abstract][Full Text] [Related]
4. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.
Köhrmann M; Jüttler E; Fiebach JB; Huttner HB; Siebert S; Schwark C; Ringleb PA; Schellinger PD; Hacke W
Lancet Neurol; 2006 Aug; 5(8):661-7. PubMed ID: 16857571
[TBL] [Abstract][Full Text] [Related]
5. Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II).
Wang Y; Liao X; Zhao X; Wang C; Liu L; Zhou Y; Wang C; Xue J; Gao P; Dong K; Ji X; Wang Y;
Int J Stroke; 2009 Feb; 4(1):49-53; discussion 49. PubMed ID: 19236499
[TBL] [Abstract][Full Text] [Related]
6. Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke.
Yoo SH; Kwon SU; Lee DH; Kim SJ; Kim JS; Kang DW
J Neurol Sci; 2010 Jul; 294(1-2):119-23. PubMed ID: 20441993
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
8. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients.
Abou-Chebl A
Stroke; 2010 Sep; 41(9):1996-2000. PubMed ID: 20651271
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours.
Röther J; Schellinger PD; Gass A; Siebler M; Villringer A; Fiebach JB; Fiehler J; Jansen O; Kucinski T; Schoder V; Szabo K; Junge-Hülsing GJ; Hennerici M; Zeumer H; Sartor K; Weiller C; Hacke W;
Stroke; 2002 Oct; 33(10):2438-45. PubMed ID: 12364735
[TBL] [Abstract][Full Text] [Related]
10. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
12. Outcome of patients with negative CT angiography results for arterial occlusion treated with intravenous thrombolysis.
Mikulik R; Goldemund D; Reif M; Aulicky P; Krupa P
Stroke; 2009 Mar; 40(3):868-72. PubMed ID: 19131650
[TBL] [Abstract][Full Text] [Related]
13. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
[TBL] [Abstract][Full Text] [Related]
14. Systemic thrombolysis based on CT or MRI stroke imaging.
Veronel D; Ringelstein A; Cohnen M; Yong M; Siebler M; Seitz RJ
J Neuroimaging; 2008 Oct; 18(4):381-7. PubMed ID: 18494775
[TBL] [Abstract][Full Text] [Related]
15. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
Berrouschot J; Röther J; Glahn J; Kucinski T; Fiehler J; Thomalla G
Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554
[TBL] [Abstract][Full Text] [Related]
16. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion.
Pagola J; Ribo M; Alvarez-Sabín J; Lange M; Rubiera M; Molina CA
Stroke; 2007 Nov; 38(11):2931-4. PubMed ID: 17901389
[TBL] [Abstract][Full Text] [Related]
17. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.
Saqqur M; Uchino K; Demchuk AM; Molina CA; Garami Z; Calleja S; Akhtar N; Orouk FO; Salam A; Shuaib A; Alexandrov AV;
Stroke; 2007 Mar; 38(3):948-54. PubMed ID: 17290031
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Lee KH; Lee SJ; Cho SJ; Na DG; Byun HS; Kim YB; Song HJ; Jin IS; Chung CS
Arch Neurol; 2000 Jul; 57(7):1000-8. PubMed ID: 10891982
[TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
20. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
